Cigna Group $CI Shares Sold by Fieldview Capital Management LLC

Fieldview Capital Management LLC trimmed its position in Cigna Group (NYSE:CI) by 41.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,598 shares of the health services provider’s stock after selling 2,496 shares during the quarter. Fieldview Capital Management LLC’s holdings in Cigna Group were worth $990,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Banco Bilbao Vizcaya Argentaria S.A. grew its position in shares of Cigna Group by 13.5% in the 3rd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider’s stock valued at $9,839,000 after buying an additional 4,066 shares during the last quarter. Compass Wealth Management LLC purchased a new position in shares of Cigna Group in the 3rd quarter valued at $4,718,000. Alberta Investment Management Corp purchased a new position in shares of Cigna Group in the 3rd quarter valued at $3,171,000. Distillate Capital Partners LLC grew its position in shares of Cigna Group by 19.1% in the 3rd quarter. Distillate Capital Partners LLC now owns 108,676 shares of the health services provider’s stock valued at $31,338,000 after buying an additional 17,442 shares during the last quarter. Finally, Colrain Capital LLC grew its position in shares of Cigna Group by 106.4% in the 3rd quarter. Colrain Capital LLC now owns 22,500 shares of the health services provider’s stock valued at $6,486,000 after buying an additional 11,600 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Trading Down 0.1%

Shares of Cigna Group stock opened at $297.77 on Monday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The company has a market capitalization of $78.77 billion, a P/E ratio of 12.62, a PEG ratio of 1.15 and a beta of 0.28. The company’s fifty day moving average is $282.53 and its two-hundred day moving average is $278.05.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. During the same period last year, the firm posted $6.74 EPS. Cigna Group’s revenue for the quarter was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Analysts forecast that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on CI. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a research report on Monday, June 1st. UBS Group increased their target price on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research report on Friday, May 22nd. Deutsche Bank Aktiengesellschaft downgraded shares of Cigna Group from a “buy” rating to a “hold” rating and dropped their target price for the company from $303.00 to $302.00 in a research report on Wednesday, May 20th. Guggenheim increased their target price on shares of Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Finally, Wells Fargo & Company increased their target price on shares of Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and a consensus price target of $338.80.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.